Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04909229Not ApplicableCompleted

Prescription Digital Therapeutic for the Treatment of Insomnia

Role: collaborator

NCT04129580Not ApplicableCompleted

reSET-O RCT (Randomized Controlled Trial)

Role: collaborator

NCT04817267Not ApplicableTerminated

Pilot Study of reSET-O to Treatment-as-usual in Acute Care Settings

Role: collaborator

NCT04325464Not ApplicableUnknown

A Remote, 9-week Insomnia Treatment Trial to Collect Real World Data for a Digital Therapeutic

Role: lead

NCT05412966Not ApplicableCompleted

Feasibility Study of Novel Prescription Digital Therapeutic Supporting Unobserved Buprenorphine Initiation & Adherence

Role: lead

NCT04542642Not ApplicableCompleted

A Remote, Decentralized Opioid Use Disorder Study to Evaluate Patient Engagement With a Game-Based Digital Therapeutic

Role: lead

All 6 trials loaded